X-153803412-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001303512.2(PDZD4):c.2269G>A(p.Ala757Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000306 in 1,143,690 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001303512.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDZD4 | NM_001303512.2 | c.2269G>A | p.Ala757Thr | missense_variant | 8/8 | ENST00000393758.7 | NP_001290441.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDZD4 | ENST00000393758.7 | c.2269G>A | p.Ala757Thr | missense_variant | 8/8 | 1 | NM_001303512.2 | ENSP00000377355.3 | ||
PDZD4 | ENST00000164640.8 | c.2251G>A | p.Ala751Thr | missense_variant | 8/8 | 1 | ENSP00000164640.4 | |||
PDZD4 | ENST00000544474.5 | c.1924G>A | p.Ala642Thr | missense_variant | 6/6 | 1 | ENSP00000442033.1 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 3AN: 112774Hom.: 0 Cov.: 25 AF XY: 0.0000286 AC XY: 1AN XY: 34930
GnomAD3 exomes AF: 0.00000789 AC: 1AN: 126749Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 42467
GnomAD4 exome AF: 0.0000310 AC: 32AN: 1030916Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 9AN XY: 332566
GnomAD4 genome AF: 0.0000266 AC: 3AN: 112774Hom.: 0 Cov.: 25 AF XY: 0.0000286 AC XY: 1AN XY: 34930
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at